Skip to main content

Advertisement

Table 1 Phenotype and transfection efficiency of the infused CART cells

From: Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma

Cycle % CAR CD3+ (%) CD3+CD4+ (%) CD3+CD8+ (%) CD3+CD56+ (%) CD8+CD56+ (%) CD45RO+ (%) CD62L+ (%) CCR7+ (%) CD45RO+CD62L+ CCR7+ (%) CD45RO+CD62L CCR7 (%)
EGFR
 1 8.99 99.14 32.77 62.26 18.98 10.64 77.93 51.01 51.3 23.61 22.42
 2 8.98 98.53 16.40 78.29 41.02 36.29 96.99 67.15 71.06 50.82 12.13
 3 8.17 98.66 53.66 45.47 7.25 4.26 94.49 76.87 40.96 20.49 3.54
CD133 6.4 95.2 23.6 71.9 11.23 8.19 94.9 74.1 51.4 41.9 12.3